CCND1 and Familial prostate cancer: According to these results, chitosan salicylaldehyde/CuFe2O4 may have a greater impact than chitosan salicylaldehyde in reducing the expression of PI3K, AKT, mTOR, and Cyclin D1, which in turn prevents the survival and proliferation of PC3 prostate cancer cells66.